ArticleMaterials (Basel, Switzerland)2026
Experimental Investigation of Mechanical Performance and Gamma Radiation Shielding of Hybrid Magnetite-Dolomite High-Density Concrete.
Article in Materials (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Nuclear infrastructure requires reliable gamma radiation shielding, for which heavyweight concrete offers a practical, structural solution. Conventional concrete provides poor gamma shielding and heat durability, demanding a denser alternative. Prior studies show that magnetite enhances attenuation and strength, while dolomite improves thermal/mechanical stability, yet findings are dispersed across materials and test conditions. Hybrid magnetite-dolomite concrete requires systematic evaluation for simultaneous optimal gamma shielding and mechanical performance under nuclear conditions. Two mixes were produced by partial replacement of coarse aggregate (Mix 1: 50% magnetite, 25% dolomite; Mix 2: 25% magnetite, 50% dolomite), casted and cured per standard practice with compressive strength measured at 7 and 28 days. Gamma attenuation was quantified using Cs-137 and Co-60. Mix 1 achieved 78.78% attenuation for Cs-137 and 76.86% for Co-60, while Mix 2 reached 77.65% and 74.68%, respectively. At 28 days, peak compressive strengths were 25.8 MPa (magnetite), 22.6 MPa (dolomite), and 20.6 MPa (control), with pre-peak energy capacity ranking as follows: magnetite > dolomite > control. Magnetite increased strength and attenuation but sharpened post-peak softening, whereas dolomite enhanced deformability and energy dissipation with minimal loss in shielding. Hybrid concrete satisfied shielding and strength targets and outperformed conventional concrete, with a magnetite-forward blend offering the best overall protection.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.